Clinical Trials Logo

Clinical Trial Summary

The main objective of this trial is to test the hypothesis that abatacept can reduce the progression of rheumatoid arthritis in ACPA+ or RF+ patients with palindromic rheumatism compared with patients treated with hydroxychloroquine.


Clinical Trial Description

The main objective of this trial is to test the hypothesis that abatacept can reduce the progression of rheumatoid arthritis in ACPA+ or RF+ patients with palindromic rheumatism compared with patients treated with hydroxychloroquine. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03669367
Study type Interventional
Source Fundacion Clinic per a la Recerca Biomédica
Contact
Status Active, not recruiting
Phase Phase 4
Start date June 3, 2019
Completion date September 30, 2024